The latest closing stock price for ProQR Therapeutics as of September 19, 2024 is 1.78.
An investor who bought $1,000 worth of ProQR Therapeutics stock at the IPO in 2014 would have $-879 today, roughly -1 times their original investment - a -19.05% compound annual growth rate over 10 years.
The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015.
The ProQR Therapeutics 52-week high stock price is 3.29, which is 84.8% above the current share price.
The ProQR Therapeutics 52-week low stock price is 1.11, which is 37.6% below the current share price.
The average ProQR Therapeutics stock price for the last 52 weeks is 1.86.
An investor who bought $1,000 worth of ProQR Therapeutics stock at the IPO in 2014 would have $-879 today, roughly -1 times their original investment - a -19.05% compound annual growth rate over 10 years.
The all-time high ProQR Therapeutics stock closing price was 24.99 on March 10, 2015.
The ProQR Therapeutics 52-week high stock price is 3.29, which is 84.8% above the current share price.
The ProQR Therapeutics 52-week low stock price is 1.11, which is 37.6% below the current share price.
The average ProQR Therapeutics stock price for the last 52 weeks is 1.86.